Menin is a tumour suppressor protein whose loss or inactivation causes multiple endocrine neoplasia 1 (MEN1), a hereditary autosomal dominant tumour syndrome that is characterized by tumorigenesis in multiple endocrine organs 1 . Menin interacts with many proteins and is involved in a variety of cellular processes [2] [3] [4] [5] [6] [7] [8] . Menin binds the JUN family transcription factor JUND and inhibits its transcriptional activity 2, 9 . Several MEN1 missense mutations disrupt the menin-JUND interaction, suggesting a correlation between the tumour-suppressor function of menin and its suppression of JUND-activated transcription 2, 10 . Menin also interacts with mixed lineage leukaemia protein 1 (MLL1), a histone H3 lysine 4 methyltransferase, and functions as an oncogenic cofactor to upregulate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis 5, 7, 11, 12 . A recent report on the tethering of MLL1 to chromatin binding factor lens epithelium-derived growth factor (LEDGF) by menin indicates that menin is a molecular adaptor coordinating the functions of multiple proteins 13 . Despite its importance, how menin interacts with many distinct partners and regulates their functions remains poorly understood. Here we present the crystal structures of human menin in its free form and in complexes with MLL1 or with JUND, or with an MLL1-LEDGF heterodimer. These structures show that menin contains a deep pocket that binds short peptides of MLL1 or JUND in the same manner, but that it can have opposite effects on transcription. The menin-JUND interaction blocks JUN N-terminal kinase (JNK)-mediated JUND phosphorylation and suppresses JUND-induced transcription. In contrast, menin promotes gene transcription by binding the transcription activator MLL1 through the peptide pocket while still interacting with the chromatin-anchoring protein LEDGF at a distinct surface formed by both menin and MLL1.
Menin is a tumour suppressor protein whose loss or inactivation causes multiple endocrine neoplasia 1 (MEN1), a hereditary autosomal dominant tumour syndrome that is characterized by tumorigenesis in multiple endocrine organs 1 . Menin interacts with many proteins and is involved in a variety of cellular processes [2] [3] [4] [5] [6] [7] [8] . Menin binds the JUN family transcription factor JUND and inhibits its transcriptional activity 2, 9 . Several MEN1 missense mutations disrupt the menin-JUND interaction, suggesting a correlation between the tumour-suppressor function of menin and its suppression of JUND-activated transcription 2, 10 . Menin also interacts with mixed lineage leukaemia protein 1 (MLL1), a histone H3 lysine 4 methyltransferase, and functions as an oncogenic cofactor to upregulate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis 5, 7, 11, 12 . A recent report on the tethering of MLL1 to chromatin binding factor lens epithelium-derived growth factor (LEDGF) by menin indicates that menin is a molecular adaptor coordinating the functions of multiple proteins 13 . Despite its importance, how menin interacts with many distinct partners and regulates their functions remains poorly understood. Here we present the crystal structures of human menin in its free form and in complexes with MLL1 or with JUND, or with an MLL1-LEDGF heterodimer. These structures show that menin contains a deep pocket that binds short peptides of MLL1 or JUND in the same manner, but that it can have opposite effects on transcription. The menin-JUND interaction blocks JUN N-terminal kinase (JNK)-mediated JUND phosphorylation and suppresses JUND-induced transcription. In contrast, menin promotes gene transcription by binding the transcription activator MLL1 through the peptide pocket while still interacting with the chromatin-anchoring protein LEDGF at a distinct surface formed by both menin and MLL1.
The amino-terminal region of MLL1 interacts with menin 12, 14, 15 . Isothermal titration calorimetry measurements showed that the menin-binding motif (residues 6-25) of MLL1 (MLL1 MBM ) is necessary and sufficient for menin binding ( Fig. 1a and Supplementary Fig. 1a -c). MLL2, the closest relative of MLL1, contains a sequence that is almost identical to MLL1 MBM at its N terminus ( Supplementary Fig. 1b) ; MLL2 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (MLL2 MBM ) binds to menin with an affinity that is comparable to that of MLL1 MBM ( Supplementary Fig. 1d ). To understand how MLL1 and MLL2 (collectively referred to as MLL) are recognized by menin, we determined the crystal structures of human menin alone or in complex with MLL1 MBM (Supplementary Fig. 2 The conformation of menin resembles a curved left 'hand' with a deep pocket formed by its 'thumb' and 'palm' (Fig. 1b, c 
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of four associated domains: an N-terminal domain characterized by a long b-hairpin, a transglutaminase-like domain that forms the thumb, a helical palm domain that contains three TPR motifs 17 and a carboxyterminal fingers domain (Fig. 1b, c, Supplementary Fig. 3 and Supplementary Information). Menin is highly conserved across species, and the conserved residues are either buried in the hydrophobic core or clustered together on a surface patch that covers the thumb and palm (Fig. 1d) . MEN1 disease-derived missense and in-frame deletion mutations are evenly distributed throughout the protein (Supplementary Fig. 4 ), indicating that all four domains are important for the in vivo function of menin ( Supplementary Fig. 4 and Supplementary Table 2 ).
The MLL1 MBM peptide adopts a compact conformation and plugs into the deep pocket of menin ( Fig. 2a and Supplementary Fig. 5 ). Mutagenesis data indicates that MLL1 MBM residues Arg 6-Trp 7-Arg 8-Phe 9-Pro 10-Ala 11-Arg 12-Pro 13 and their interacting residues in menin contribute the most towards the interaction (Supplementary Figs 6 and 7, and Supplementary Tables 3 and 4) . The side-chain of Phe 9 MLL1 fits into a hydrophobic cavity formed by the thumb and palm of menin (Fig. 2b) . A menin Met278Trp substitution altered the cavity shape and led to complete loss of binding (Supplementary Table 4 ). The MLL1 MBM -binding pocket is highly acidic (Fig. 2c) . The two C-terminal arginine residues (Arg 24 and Arg 25) in MLL1 MBM are disordered, but they seem to be important for interaction, given that glutamate substitution resulted in a 21-fold decrease in binding affinity (Supplementary Table 3 ). Consistent with this, mutation of the acidic residues of menin also led to decreased binding (Supplementary Table 4 ). Next, we examined the MLL1 MBM -binding activity of several MEN1 disease-derived mutations (His139Asp, Cys241Phe, Ala242Val, Gly281Arg, Ala284Gln, and Thr344Arg). Except for Ala284Gln and Thr344Arg, which yielded insoluble proteins, the remaining mutants impaired the menin-MLL1 MBM interaction (Supplementary Table 4 ). To further examine the menin-MLL1 interaction in vivo, we studied the interactions of mutant proteins that are transiently expressed in human embryonic kidney 293T cells. Consistent with the isothermal titration calorimetry analysis, co-immunoprecipitation data showed that mutations of the key residues at the interface completely abolished the menin-MLL1 interaction in cells (Fig. 2d) .
Menin upregulates the expression of homeobox genes Hoxc8 and Hoxc6 (ref. 5) . To test the effect of the menin-MLL interaction on the expression levels of Hoxc8 and Hoxc6, wild-type and MLL-binding deficient mutants of menin were individually used to complement menin-null mouse embryonic fibroblasts. Western blot analyses indicated comparable expression of wild-type and mutant proteins in cells ( Supplementary Fig. 8a ). When Men1 2/2 cells were complemented with wild-type menin, expression of Hoxc8 and Hoxc6 dramatically increased compared to vector-expressing cells ( Fig. 2e and Supplementary Fig. 8b ). In contrast, overexpression of the menin mutants in Men1 2/2 cells failed to upregulate the messenger RNA levels of Hoxc8 or Hoxc6 ( Fig. 2e and Supplementary Fig. 8b ), suggesting that the menin-MLL interaction is essential for Hoxc8 and Hoxc6 expression.
Next we performed chromatin immunoprecipitation (ChIP) assays to determine the binding of mutant menin at the Hoxc8 promoter. Except for Ala284Gln (a mutant that leads to insoluble proteins), all other mutants bound to the Hoxc8 promoter as effectively as wild-type menin (Fig. 2f) . Expression of wild-type or mutant menin did not greatly affect H3 distribution at the Hoxc8 promoter (Supplementary Fig. 8c ). Notably, Men1 2/2 cells complemented with wild-type menin exhibited a substantial increase in MLL1 binding and histone H3K4me3 trimethylation at the Hoxc8 promoter compared with vector-expressing or mutant-menin-expressing cells (Fig. 2f) . Therefore, although menin mutants were able to bind to the Hoxc8 promoter, their ability to recruit MLL1 and thus establish H3K4me3 at the Hoxc8 promoter was compromised, resulting in reduced Hoxc8 expression.
LEDGF, a chromatin-associated protein 18 , is required for MLL1-dependent transcription and leukaemic transformation 13 . Isothermal titration calorimetry measurement showed that a complex composed of menin and an N-terminal fragment of MLL1, called MLL1 MBM-LBM (comprising residues 6-153 and including both menin-binding and LEDGF-binding motifs) binds to the integrase binding domain of LEDGF (LEDGF IBD ) with an affinity of 470 nM ( Fig. 3a and Supplementary Fig. 9a ). In contrast, neither menin nor MLL1 MBM-LBM alone could interact with LEDGF IBD (Supplementary Fig. 9b ) 13 . We determined the menin-MLL1 MBM-LBM -LEDGF IBD complex structure at a resolution of 3.0 Å ( Supplementary Fig. 9c and Supplementary Table 1 ). MLL1 MBM-LBM exhibits an extended conformation and binds to menin through two major sites (Fig. 3b) ; the N-terminal MLL1 MBM coil folds into the high-affinity pocket of menin in the same manner as in the menin-MLL1 MBM structure (Supplementary Figs 9d, e) , whereas the C-terminal helix a2 packs on the surface of the N-terminal domain of menin to form a V-shaped groove for LEDGF IBD binding ( Fig. 3b and Supplementary Fig. 9f ). The middle loop of MLL1 MBM-LBM spans a large distance on menin without many specific interactions except for two leucine residues (Leu 106 and Leu 116) with side-chains that point to 
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two shallow pockets on the menin surface, defining the path of the loop ( Fig. 3c and Supplementary Fig. 9g ). Helix aE of LEDGF IBD is sandwiched between helices a2 of MLL1 and a4 of menin through both hydrophobic and electrostatic interactions (Fig. 3d) . In support of the crystal structure, mutations of residues on the a4 helix of the N-terminal domain of menin (Ala95Arg and Ser104Tyr) specifically disrupted the interaction with LEDGF (Supplementary Table 5 and Supplementary Fig. 10 ). Notably, Men1 2/2 cells that were complemented with these two mutants failed to stimulate Hoxc8 expression ( Supplementary Fig. 11 ), suggesting that a functional menin-MLL1-LEDGF complex is required for upregulation of Hoxc8 expression. Together, our data show that menin functions as an adaptor molecule to modulate gene expression by binding MLL1 at one site while also interacting with LEDGF at a distinct surface.
Although MLL1 and MLL2 share many functional motifs, including the menin-binding motif ( Supplementary Fig. 12 ), MLL2 does not contain a LEDGF-binding motif sequence and thus would not form a ternary complex with menin and LEDGF. Given that the PWWP domain of LEDGF, which contains a relatively well conserved ProTrp-Trp-Pro signature, is required for MLL1-mediated leukaemic transformation 13, 18 , the inability of MLL2 to form a menin-MLL2-LEDGF complex explains why only MLL1, and not MLL2, has so far been described as a proto-oncogene that can be activated by chromosomal translocations.
Menin also interacts directly with transcription factor JUND 2, 9 . We defined JUND residues 27-47 as the menin-binding motif (JUND MBM ) with an affinity of 1.6 mM (Fig. 4a and Supplementary  Fig. 13 ). Sequence comparison of JUND MBM and MLL1 MBM revealed a striking similarity (Fig. 4a) , suggesting that JUND MBM might interact with menin through the same binding pocket as does MLL1 MBM . Consistent with this idea, both isothermal titration calorimetry and glutathione S-transferase (GST) pull-down assays showed that MLL1 could efficiently compete with JUND for menin binding (Supplementary Fig. 14) .
We determined the menin-JUND MBM complex structure, which shows many similarities to the menin-MLL1 MBM structure (Fig. 4b  and Supplementary Table 1) . First, the Phe-Pro-(Ala or Gly)-(Arg or Ala)-Pro motifs in both menin-binding motifs are almost identical in overall conformation (Supplementary Fig. 15a) . Second, Phe32, Pro33 and Pro36 of JUND interact with menin in the same way as their counterparts in MLL1 MBM (Supplementary Fig. 15b, c) . Notably, two lysine residues (Lys 46 and Lys 47) in JUND MBM , equivalent to the disordered Arg 24 and Arg 25 in MLL1 MBM , are visible in the electron density map and point to an acidic surface on menin (Supplementary Fig. 15c ). Mutation of these lysine residues and other key binding residues at the interface abolished or weakened the interaction both in vitro and in vivo (Fig. 4c, Supplementary Fig. 16 and Supplementary Table 6 ).
Menin uncouples JUND phosphorylation from JNK activation, but the mechanism is poorly understood 19 . The consensus JNK-docking domain (D-domain) contains a cluster of basic amino acids preceding two leucine residues 20 ( Fig. 4d) . JUND MBM is partially overlapped with a putative D-domain of JUND (JUND D ) 21 ( Fig. 4d) . Both the basic residues and the leucine residues in JUND D are indispensable for JNK docking on JUND as well as JNK-mediated JUND phosphorylation (Fig. 4e, f and Supplementary Fig, 17a, b) . Thus, Lys 46 and Lys 47 are both required for menin binding and JUND phosphorylation by 
Phosphor-JUND
Phosphor-c-JUN
Basic cluster LXL motif KXXKX (1-4) LXL JNK-docking domain consensus sequence

Hs_JUND 1 ----METPFYGDEALSGLGGGASGSGGSFASPGRLFPGAPPTAAAGSMMKKDALTLSLSEQV 58
Hs_c-JUN 1 MTAKMETTFYDDALNASFLPSESGPYG-YSNP---------------KILKQSMTLNLADPV 46
Hs_JUND 59 AAALKPAAAPPPTPLRADGAPSAAPPDGLLASPDLGLLKLASPELERLIIQS-NGLVTTTPT 119 
Hs_c-JUN 47 G-SLKP-------HLRAKNS-------DLLTSPDVGLLKLASPELERLIIQSSNGHITTTPT
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JNK. This led us to test whether menin inhibits JUND phosphorylation through sequestering JUND from JNK. In GST-pull-down assay, GST-JUND can only pull down JNK in the absence of menin, indicating that menin has a higher affinity to JUND ( Fig. 4e and Supplementary  Fig. 17a ). Furthermore, when menin was added, phosphorylation of JUND was clearly inhibited ( Fig. 4g and Supplementary Fig. 17c ). In contrast, phosphorylation of menin-binding-deficient mutants of JUND was not affected by menin ( Fig. 4g and Supplementary  Fig. 17c ). Next, we examined whether menin could inhibit JUND phosphorylation in response to anisomycin activation of JNK in 293T cells 19 . Although wild-type JUND phosphorylation was suppressed by menin, menin-binding deficient mutants remained robustly phosphorylated in the presence of menin (Fig. 4h) . Notably, menin had no effects on JNK binding and JNK-mediated phosphorylation of c-JUN, a close homologue of JUND that lacks a menin-binding motif (Fig. 4d, e, g and Supplementary Fig. 17a, c, d ). Together, our findings reveal that the menin-JUND interaction blocks JNK docking on JUND and inhibits the JNK-mediated phosphorylation.
Menin represses JUND-mediated transcriptional activation 2, 9 . To examine whether this repression depends on the menin-JUND interaction, wild-type or menin-binding-deficient mutants of JUND were co-transfected into 293T cells with an AP1 luciferase reporter plasmid in the presence or absence of menin ( Supplementary Fig. 17e ). Consistent with previous studies, transactivation by JUND was effectively repressed by menin 2, 9 (Fig. 4i) . In contrast, menin exhibited a marginal effect on mutant JUND-mediated transcriptional activation (Fig. 4i) . We recently demonstrated that JUND induces gastrin gene expression in human AGS gastric cells and that this induction can be suppressed by menin 22 . Consistent with the luciferase assay, menin failed to suppress the gastrin upregulation that was induced by mutant JUND, suggesting that the menin-JUND interaction is important in gastrin expression regulation (Supplementary Fig. 18 ). Thus, we conclude that the menin-JUND interaction plays a key part in suppressing JUND-mediated transcriptional activation.
In summary, our structural and functional studies provide a mechanistic explanation of how menin could both positively and negatively regulate gene transcription. Our findings also provide evidence that menin acts as a scaffold protein to assemble a menin-MLL1-LEDGF ternary complex to coordinate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis.
METHODS SUMMARY
Human menin, LEDGF IBD and the MLL and JUND peptides were expressed in Escherichia coli BL21(DE3) and purified by sequential affinity and gel-filtration chromatography purification. Menin crystals were obtained in sitting drops over 100 mM sodium cacodylate (pH 6.5) and 1.4 M sodium acetate. Crystallization of menin with the MLL1 MBM or JUND MBM peptides was achieved by sitting-drop diffusion with a well solution containing 100 mM Tris-HCl (pH 7.0), 200 mM MgCl 2 and 2.3 M NaCl. The menin-MLL1 MBM-LBM -LEDGF IBD complex was crystallized by hanging-drop vapour diffusion against a well solution of 50 mM HEPES (pH 7.0), 1.6 M (NH 4 ) 2 SO 4 , 10 mM MgCl 2 , 0.016% L-canavanine, 0.016% O-phospho-L-serine, 0.016% taurine, 0.016% quinine, 0.016% sodium glyoxylate monohydrate and 0.016% cholic acid, and were dehydrated with the solution containing 50 mM HEPES (pH 7.0), 2.3 M (NH 4 ) 2 SO 4 and 10 mM MgCl 2 . The menin-MLL1 MBM complex structure was determined by multi-wavelength anomalous dispersion to a resolution of 3.0 Å . The structures of menin alone, the menin-MLL1 MBM-LBM -LEDGF IBD ternary complex, and the menin-JUND MBM complex were solved by molecular replacement and refined to resolutions of 2.5 Å , 3.0 Å and 2.85 Å , respectively.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Protein expression and purification. To facilitate crystallization, we genetically deleted an unstructured loop (residues 460-519) in menin, a short fragment (residues 40-45) in JUND MBM and two loop regions (residues 16-22 and 36-102) in MLL1 MBM-LBM . All the resulting proteins retain wild-type-like binding affinities (Supplementary Figs 2d, 9c and 13d ). For simplicity, MeninD, JUND MBM D and MLL1 MBM-LBM D are referred to as menin, JUND MBM , and MLL1 MBM-LBM , respectively, unless stated otherwise.
Various human menin proteins and the MLL and JUND peptides were expressed in E. coli BL21(DE3) using a modified pET28b vector with a SUMO protein fused at the N terminus after the His 6 tag. After induction for 16 h with 0.1 mM isopropylthiogalactoside (IPTG) at 25 uC, the cells were collected by centrifugation and the pellets were resuspended in lysis buffer (50 mM TrisHCl, pH 8.0; 50 mM NaH 2 PO 4 ; 400 mM NaCl; 3 mM imidazole; 10% glycerol; 0.1 mg ml 21 lysozyme; 2 mM 2-mercaptoethanol; 1 mM PMSF; 5 mM benzamidine; 1 mg ml 21 leupeptin; and 1 mg ml 21 pepstatin). The cells were then lysed by sonication and the cell debris was removed by ultracentrifugation. The supernatant was mixed with Ni-NTA agarose beads (Qiagen) and rocked for 2 h at 4 uC before elution with 250 mM imidazole. Ulp1 protease was then added to remove the His 6 -SUMO tag. After Ulp1 digestion, the menin proteins and the MLL and JUND peptides were further purified by gel-filtration chromatography on Hiload Superdex 200 and Hiload Superdex 75 columns (GE Healthcare), equilibrated with buffer A (25 mM Tris-HCl, pH 8.0; 150 mM NaCl; and 5 mM dithiothreitol (DTT)) and buffer B (100 mM ammonium bicarbonate), respectively. The purified menin proteins were concentrated to 25 mg ml 21 and stored at 280 uC. The purified peptides were lyophilized and resuspended in water at a concentration of 50 mg ml 21 and stored at 280 uC.
For the menin-MLL1 MBM-LBM -LEDGF IBD complex, we cloned LEDGF IBD into a modified pET28b vector with a SUMO protein fused at the N terminus after the His 6 tag. MLL1 MBM-LBM was cloned into a GST fusion protein expression vector, pGEX6p-1 (GE healthcare). The menin-MLL1 MBM-LBM complex and LEDGF IBD itself were expressed in E. coli BL21(DE3), respectively. The menin-MLL1 MBM-LBM complex was purified by sequential affinity chromatography with Ni-NTA agarose beads and glutathione sepharose 4B beads (GE Healthcare). After removal of the His 6 -UMO tag and GST tag with Ulp1 and Protease 3C, respectively, the complex was purified further with gel-filtration chromatography on a Hiload Superdex 200. Meanwhile, LEDGF IBD was purified in the same way as menin and then mixed with the purified menin-MLL1 MBM-LBM complex with a molar ratio of 2:1. After 1 h incubation on ice, the protein mixtures were purified again with gel-filtration chromatography on a Hiload Superdex 200 column.
For the in vitro assays, mutant menin proteins were expressed in E. coli and purified following the procedure described above. All the mutant menin proteins displayed unaltered biophysical properties as analysed by gel-filtration chromatography (data not shown), ensuring that the altered affinities of the menin mutants for MLL1 MBM , MLL1 MBM-LBM -LEDGF IBD and JUND MBM are not attributable to a change in the structural integrity of the resulting proteins. Crystallization, data collection and structure determination. Menin was crystallized by sitting-drop vapour diffusion at 4 uC. The precipitant solution contained 100 mM sodium cacodylate trihydrate (pH 6.5) and 1.4 M sodium acetate trihydrate. For the menin-MLL1 MBM complex, purified menin was first mixed with the MLL1 MBM peptide at a molar ratio of 1:2 and then the mixture was incubated on ice for 1 h to allow complex formation. Crystallization of the complex was achieved by sitting-drop vapour diffusion at 4 uC with the well solution containing 100 mM Tris-HCl (pH 7. All of the crystals were gradually transferred into a harvesting solution containing the respective precipitant solutions plus 5 M sodium formate, before being flash-frozen in liquid nitrogen for storage. Data were collected under cryogenic conditions (100 K). Selenomethionine-multi-wavelength anomalous dispersion data set of the menin-MLL1 MBM complex at the Se peak and inflection wavelengths were collected at the Advanced Photon Source (APS) beamline 21-ID-D and processed using HKL2000 (ref. 23) . Seven selenium atoms were located and refined, and the multiwavelength anomalous diffraction data phases were calculated using SHARP 24 . The initial multi-wavelength anomalous dispersion map of the menin-MLL1 MBM complex was substantially improved by solvent flattening. A model was manually built into the modified experimental electron density using O (ref. 25 ) and further refined in Phenix 26 . Native data sets of menin and the menin complexes were collected at the APS beamline 21-ID-D and processed using HKL2000. The structures were determined by molecular replacement using Phaser in the CCP4i suite 27 and further refined in Phenix. The majority (,95%) of the residues in all structures lie in the most favoured region in the Ramachandran plot, and the remaining structures lie in the additionally stereochemically allowed regions in the Ramachandran plot. Isothermal titration calorimetry. The equilibrium dissociation constants of the menin-MLL MBM , menin-JUND MBM and menin-MLL1 MBM-LBM -LEDGF IBD interactions were determined using a VP-ITC calorimeter (MicroCal). The binding enthalpies were measured at 20 uC in 25 mM Tris-HCl (pH 8.0) and 150 mM NaCl. Two independent experiments were performed for every interaction described here. Isothermal titration calorimetry data were subsequently analysed and fitted using Origin 7 software (OriginLab) with blank injections of peptides into buffer subtracted from the experimental titrations before data analysis. Yeast two-hybrid assay. The yeast two-hybrid assays were performed using the yeast L40 strain harbouring pBTM116 and pACT2 (Clontech) fusion plasmids. The colonies containing both plasmids were selected on -Leu -Trp plates. The activities of b-galactosidase were measured according to Clontech MATCHMAKER library protocol and the averages from three individual transformants were reported. Plasmid construction. To generate recombinant retroviruses, pMX-23 FLAGmenin was constructed by inserting polymerase chain reaction (PCR)-amplified menin cDNA into the BamHI/NotI site of the retroviral vector pMX-23 FLAG. To generate menin mutants, pMX-23 FLAG -menin was used as a template for site-directed mutagenesis using the QuikChange kit from Agilent. Cell culture and transfection. Menin-null MEFs, HEK293T and the human AGS gastric adenocarcinoma cell line were cultured in Dulbecco's modified Eagle's medium complemented with 10% fetal calf serum and 1% PenStrep. Menin-null MEFs were infected with empty vector, wild-type or mutant menin-expressing retroviruses and were subjected to puromycin selection (2 mg ml
21
) 72 h postinfection for 2 days. AGS and 293T cells were transiently transfected with the indicated expression vectors using Lipofectamine 2000 (Invitrogen) for 48 h. Co-immunoprecipitation. Human 293T cells were transfected with pcDNA3.1 vectors encoding c-MYC-tagged MLL1 (residues 1-153) and FLAG-tagged menin. Two days after transfection the cells were resuspended in 1 ml of lysis buffer (20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1.0% Triton X-100; 1 mM EDTA; and protease inhibitor cocktail). Immunoprecipitation of lysates was conducted using 20 ml anti-FLAG M2 affinity agarose (Sigma). After washing with lysis buffer, immunoprecipitated proteins were eluted with 32 loading buffer (50 mM Tris-HCl, pH 6.8; 2% SDS; 10% 2-mercaptoethanol; 10% glycerol; and 0.002% bromophenol blue), subjected to protein gel-electrophoresis using 4-20% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a polyvinylidene fluoride (PVDF) membrane. After blocking with TBST buffer containing 5% skimmed milk, proteins on the membrane were detected by western blot using anti-FLAG (Sigma) and anti-c-MYC (Santa Cruz Biotechnology) antibodies. The same procedure was also used for the co-immunoprecipitation experiments for menin and JUND. Quantitative real-time PCR analysis. Exponentially growing MEFs were seeded at 2 3 10 5 cells per 100-mm dish and harvested 2 days later. AGS cells were transfected with the menin and JUND expression vectors for 48 h. Total RNA was isolated with an RNeasy minikit from Qiagen. Quantitative real-time PCR (qRT-PCR) was performed in an ABI 7500 Real Time PCR system (Applied Biosystems). ChIP assay. MEFs were cross-linked with 1% formaldehyde for 10 min at 37 uC. Cross-linking was stopped by addition of 125 mM glycine. The ChIP assay was performed using the QuikCHIP kit from Imgenex, according to the manufacturer's instructions. Antibodies used for ChIP were anti-menin (Bethyl labs), anti-MLL1, anti-histone H3K4me3, anti-histone H3 and IgG (Abcam). Antibody-precipitated DNA-protein complex was reverse cross-linked, and the DNA was isolated using phenol-chloroform extraction and the precipitated DNA was used as the template for PCR. GST-pull-down assay. GST, GST-fused c-JUN (residues 1-246), GST-fused JUND (residues 1-150) and FLAG-tagged JNK3 were expressed in E. coli BL21(DE3) and were purified to homogeneity. GST-pull-down assays were performed by incubating 10 mg of GST or GST-JUN, 10 mg of FLAG-JNK3 with 10 ml of glutathione sepharose 4B beads and either with or without 20 mg of full-length menin in binding buffer (50 mM Tris-HCl (pH 8.0) and 150 mM NaCl) at 4 uC overnight. The beads were then extensively washed with binding buffer four times and the bound proteins were eluted with 10 mM reduced glutathione in binding buffer. After separation on 15% SDS-PAGE and Ponceau S staining, FLAG-tagged JNK3 protein was detected by western blot using anti-FLAG antibody.
In vitro kinase assay. WT c-JUN (residues 1-246) and WT or mutant JUND proteins (residues 1-150) were expressed in E. coli BL21(DE3) and purified as LETTER RESEARCH
